A detailed history of Perkins Capital Management Inc transactions in Iridex Corp stock. As of the latest transaction made, Perkins Capital Management Inc holds 45,300 shares of IRIX stock, worth $97,848. This represents 0.12% of its overall portfolio holdings.

Number of Shares
45,300
Previous 40,100 12.97%
Holding current value
$97,848
Previous $113,000 18.58%
% of portfolio
0.12%
Previous 0.1%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$2.35 - $3.1 $12,220 - $16,120
5,200 Added 12.97%
45,300 $134,000
Q4 2023

Jan 22, 2024

SELL
$1.9 - $3.28 $285 - $491
-150 Reduced 0.37%
40,100 $113,000
Q3 2023

Nov 02, 2023

SELL
$1.33 - $2.54 $13,566 - $25,908
-10,200 Reduced 20.22%
40,250 $102,000
Q2 2023

Jul 21, 2023

BUY
$1.76 - $2.43 $9,680 - $13,365
5,500 Added 12.24%
50,450 $109,000
Q1 2023

May 09, 2023

BUY
$2.0 - $2.46 $3,000 - $3,690
1,500 Added 3.45%
44,950 $91,000
Q4 2022

Jan 26, 2023

BUY
$2.0 - $2.42 $6,000 - $7,260
3,000 Added 7.42%
43,450 $87,000
Q3 2022

Oct 24, 2022

SELL
$2.42 - $3.41 $96,548 - $136,045
-39,896 Reduced 49.66%
40,450 $97,000
Q2 2022

Jul 29, 2022

BUY
$2.48 - $4.66 $27,280 - $51,260
11,000 Added 15.86%
80,346 $206,000
Q1 2022

Apr 20, 2022

BUY
$3.99 - $6.42 $22,344 - $35,952
5,600 Added 8.78%
69,346 $321,000
Q4 2021

Feb 10, 2022

BUY
$5.62 - $9.37 $8,430 - $14,054
1,500 Added 2.41%
63,746 $389,000
Q2 2021

Jul 28, 2021

SELL
$6.67 - $9.2 $66,700 - $92,000
-10,000 Reduced 13.84%
62,246 $439,000
Q1 2021

Apr 28, 2021

SELL
$2.18 - $7.71 $42,728 - $151,116
-19,600 Reduced 21.34%
72,246 $488,000
Q4 2020

Feb 09, 2021

SELL
$1.62 - $2.91 $19,440 - $34,920
-12,000 Reduced 11.56%
91,846 $231,000
Q3 2020

Oct 28, 2020

BUY
$1.78 - $2.51 $72,527 - $102,272
40,746 Added 64.57%
103,846 $204,000
Q1 2020

Apr 29, 2020

BUY
$1.4 - $3.64 $13,300 - $34,580
9,500 Added 17.72%
63,100 $100,000
Q4 2019

Feb 03, 2020

BUY
$1.77 - $2.57 $16,372 - $23,772
9,250 Added 20.86%
53,600 $120,000
Q3 2019

Oct 23, 2019

SELL
$1.57 - $4.43 $85,251 - $240,548
-54,300 Reduced 55.04%
44,350 $82,000
Q2 2019

Aug 09, 2019

SELL
$4.39 - $5.61 $6,584 - $8,415
-1,500 Reduced 1.5%
98,650 $449,000
Q1 2019

Apr 22, 2019

SELL
$4.14 - $5.18 $29,393 - $36,778
-7,100 Reduced 6.62%
100,150 $457,000
Q4 2018

Feb 11, 2019

SELL
$3.85 - $6.3 $464,695 - $760,410
-120,700 Reduced 52.95%
107,250 $504,000
Q3 2018

Oct 22, 2018

BUY
$6.0 - $9.15 $936,000 - $1.43 Million
156,000 Added 216.82%
227,950 $1.45 Million
Q2 2018

Aug 02, 2018

BUY
$5.33 - $7.24 $71,955 - $97,740
13,500 Added 23.1%
71,950 $501,000
Q1 2018

Apr 23, 2018

BUY
$5.72 - $8.28 $29,744 - $43,056
5,200 Added 9.77%
58,450 $334,000
Q4 2017

Jan 26, 2018

SELL
$7.62 - $9.94 $269,367 - $351,379
-35,350 Reduced 39.9%
53,250 $406,000
Q3 2017

Oct 31, 2017

BUY
$8.19 - $10.25 $725,634 - $908,150
88,600
88,600 $830,000

Others Institutions Holding IRIX

About IRIDEX CORP


  • Ticker IRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 15,985,600
  • Market Cap $34.5M
  • Description
  • IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...
More about IRIX
Track This Portfolio

Track Perkins Capital Management Inc Portfolio

Follow Perkins Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perkins Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perkins Capital Management Inc with notifications on news.